Implanet SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0013470168
EUR
0.20
0 (-0.98%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 30 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-3.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.5%
0%
1.5%
6 Months
-41.11%
0%
-41.11%
1 Year
94.82%
0%
94.82%
2 Years
189.59%
0%
189.59%
3 Years
23.63%
0%
23.63%
4 Years
-24.73%
0%
-24.73%
5 Years
-80.43%
0%
-80.43%

Implanet SA for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
15.72%
EBIT Growth (5y)
-18.11%
EBIT to Interest (avg)
-4.42
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
3.95
Sales to Capital Employed (avg)
2.21
Tax Ratio
1.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
NA
EV to EBIT
-5.15
EV to EBITDA
-6.02
EV to Capital Employed
-9.36
EV to Sales
2.25
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
NA

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Implanet SA"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 32.98% vs 27.03% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 15.38% vs 22.39% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.50",
          "val2": "9.40",
          "chgp": "32.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.20",
          "val2": "-3.80",
          "chgp": "-10.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.30",
          "chgp": "-66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.40",
          "val2": "-5.20",
          "chgp": "15.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-338.00%",
          "val2": "-519.60%",
          "chgp": "18.16%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
12.50
9.40
32.98%
Operating Profit (PBDIT) excl Other Income
-4.20
-3.80
-10.53%
Interest
0.10
0.30
-66.67%
Exceptional Items
0.00
-0.10
100.00%
Consolidate Net Profit
-4.40
-5.20
15.38%
Operating Profit Margin (Excl OI)
-338.00%
-519.60%
18.16%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 32.98% vs 27.03% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 15.38% vs 22.39% in Dec 2024

stock-summaryCompany CV
About Implanet SA stock-summary
stock-summary
Implanet SA
Pharmaceuticals & Biotechnology
Implanet SA is a France-based company. It is involved in the design, production and marketing of medical equipment, such as medical implants and devices used in orthopedic surgery. The Company's products include prosthetic knees, spinal bracing systems, intersomatic cages, pins, suture threads, screws and anchors, among others. Its brands portfolio includes Spine System and Jazz. The Implanet Spine System aims to provide immobilization and stabilization of the spinal segments in skeletally mature patients as an adjunct to fusion of the thoracic, lumbar and sacral spine. The Implanet Jazz System, its flagship product, is an implant used to improve the treatment of spinal conditions requiring vertebral fusion.
Company Coordinates stock-summary
Company Details
Technopole Bordeaux Montesquieu, Allee Francois Magendie MARTILLAC None : 33650
stock-summary
Tel: 33 5 5799555533 5 57995555
stock-summary
Registrar Details